EMR vs Ghana: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
EMR
72.0%
in 2025
Ghana
91.0%
in 2025
EMR rank
1st
Ghana rank
1st
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- EMR
- Ghana
How they compare
Ghana currently reports 91.0% against 72.0% in EMR, a difference of 19.0%.
That makes Ghana's figure about 1.3 times EMR's.
The two have swapped places 3 times across 10 shared years of data; in 2016 it was EMR ahead.
EMR ranks 1st and Ghana ranks 1st of 7 groups.
Across the 2 decades both report, EMR averaged higher in 1 and Ghana in 1.
Head to head by decade
| Decade | EMR | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.2% | 64.2% | 9.0% | EMR |
| 2020s | 68.2% | 82.5% | 14.3% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), EMR or Ghana?
- Ghana, at 91.0% against 72.0% in EMR as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between EMR and Ghana?
- 19.0%, with Ghana ahead.
- How many years of comparable data are there for EMR and Ghana?
- 10 years are reported by both, from 2016 to 2025.
- How do EMR and Ghana rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- EMR ranks 1st and Ghana ranks 1st of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.